Skip to main content

Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes



The emergence of multi-drug resistant (MDR) phenotypes is a major public health problem today in the treatment of bacterial infections. The present study was designed to evaluate the antibacterial activities of the methanol extracts of eleven Cameroonian spices on a panel of twenty nine Gram negative bacteria including MDR strains.


The phytochemical analysis of the extracts was carried out by standard tests meanwhile the liquid micro-broth dilution was used for all antimicrobial assays.


Phytochemical analysis showed the presence of alkaloids, phenols and tannins in all plants extracts. The results of the antibacterial assays indicated that all tested extracts exert antibacterial activities, with the minimum inhibitory concentration (MIC) values varying from 32 to 1024 μg/ml. The extracts from Dichrostachys glomerata, Beilschmiedia cinnamomea, Aframomum citratum, Piper capense, Echinops giganteus, Fagara xanthoxyloïdes and Olax subscorpioïdea were the most active. In the presence of efflux pump inhibitor, PAßN, the activity of the extract from D. glomerata significantly increased on 69.2% of the tested MDR bacteria. At MIC/5, synergistic effects were noted with the extract of D. glomerata on 75% of the tested bacteria for chloramphenicol (CHL), tetracycline (TET) and norfloxacin (NOR). With B. cinnamomea synergy were observed on 62.5% of the studied MDR bacteria with CHL, cefepime (FEP), NOR and ciprofloxacin (CIP) and 75% with erythromycin (ERY).


The overall results provide information for the possible use of the studied extracts of the spices in the control of bacterial infections involving MDR phenotypes.

Peer Review reports


The emergence of MDR phenotypes is a major public health problem today in the treatment of bacterial infections. The multi-drug resistance of Gram negative bacteria is a major cause of morbidity and mortality in health care services [1]. The activation of bacterial efflux pumps also plays an important role in the appearance of resistance to antibiotics [2]. The real challenge for scientists worldwide today, is to continuously find new drugs to combat resistant microorganisms, or compounds which are able to inhibit the resistance mechanisms of pathogens, therefore restoring the activity of antibiotics. Medicinal plants are rich in compounds which may be potential natural drugs and serve as alternative, less expensive and safe antimicrobials for the treatment of common ailments. Plant drugs are widely used in Africa for the treatment of many ailments and constitute the first health recourse for about 80% of the population [3]. A number of pharmaceutical products in current use worldwide are derived from plants [4]. In Cameroon, many medicinal plants including spices are used as herbal medicines. The present work was therefore designed to investigate the antibacterial potential against MDR bacteria of some of the commonly used medicinal spices in Cameroon such as Fagara xantoxyloides Watern., Dichrostachys glomerata (Forsk) Chuov, Olax subscorpioïdea Oliv., Solanum melongeua L. Var inerme D.C Hiern, Piper capense Lin.f, Xylopia aethiopica Dunal A. Rich., Aframomum citratum (Pereira). Schum, Scorodophloeus zenkeri Harms., Beilschmiedia cinnamomea (Stapf) Robyns & Wilczek, Echinops giganteus A. Rich and Mondia whitei (Hook F). Skell. This study was also extended to the evaluation of the potencies of the above plant extracts to increase the activity of some antibiotics on MDR bacteria. The role of bacterial efflux pumps in resistance to the extracts was also studied.


Plant materials and extraction

The eleven edible spices used in this work were purchased from Dschang local market, West Region of Cameroon in January 2010. The collected spices materials were: the fruits of Fagara xanthoxyloides, Dichrostachys glomerata, Olax subscorpioïdea, Solanum melongeua, Piper capense and Xylopia aethiopica, the bark of Aframomum citratum, Scorodophloeus zenkeri, Beilschmiedia cinnamomea and the roots of Echinops giganteus and Mondia whitei. The plants were identified by Mr. Fulbert Tadjouteu of the National herbarium (Yaoundé, Cameroon) where voucher specimens were deposited under the reference numbers (Table 1).

Table 1 Spices used in the present study and evidence of their activities.

The air dried and powdered sample (1 kg) from each spice was extracted with methanol (MeOH) for 48 h at room temperature. The extract was then concentrated under reduced pressure to give residues which constituted the crude extracts. They were then kept at 4°C until further use.

Preliminary phytochemical investigations

The major classes of secondary metabolites; alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, saponins, tannins, steroids and triterpenes were screened according to the common phytochemical methods described by Harborne [5] with some modifications. Briefly, for alkaloids (5 mg plant extract in 10 ml methanol); a portion of 2 ml extract + 1% HCl + steam, 1 ml filtrate + 6 drops of Mayor's reagents/Wagner's reagent/Dragendroff reagent; creamish precipitate/brownish-red precipitate/orange precipitate indicated the presence of respective alkaloids. For tannins (5 mg plant extract in 10 ml distilled water); a portion of 2 ml + 2 ml FeCl3; blue-black precipitate indicated the presence of tannins. For saponins (frothing test: 0.5 ml filtrate + 5 ml distilled water); frothing persistence indicated presence of saponins. For steroids and triterpenoids (Liebermann-Burchard reaction: 5 mg plant extract in 10 ml chloroform, filtered); a 2 ml filtrate + 2 ml acetic anhydride + conc. H2SO4. Blue-green ring or pink-purple indicated the presence of steroids or triterpenoids. For flavonoids (5 mg plant extract in 10 ml methanol); a portion of 2 ml + conc. HCl + magnesium; ribbon pink-tomato red color indicated the presence of flavonoids. For anthocyanins (5 mg plant extract in 10 ml methanol); a portion 2 ml + 1%HCl +heating; orange color indicated the presence of anthocyanins. For anthraquinones (5 mg plant extract in 10 ml methanol); a portion of 2 ml + 2 ml ether-chloroform 1:1 v/v + 4 ml NaOH 10% (w/v); red color indicated the presence of anthraquinones. For phenols (5 mg plant material in 10 ml methanol); a portion of 2 ml + 2 ml FeCl3; violet-blue or greenish color indicated the presence of phenols.

Chemicals for antimicrobial assays

Tetracycline (TET), cefepime (FEP), streptomycin (STR), ciprofloxacin (CIP), norfloxacin (NOR), chloramphenicol (CHL), cloxacillin (CLX), ampicillin (AMP), erythromycin (ERY), kanamycin (KAN) (Sigma-Aldrich, St Quentin Fallavier, France) were used as reference antibiotics. p-Iodonitrotetrazolium chloride (INT) and phenylalanine arginine β-naphthylamide (PAßN) were used as microbial growth indicator and efflux pumps inhibitor respectively.

Bacterial strains and culture media

The studied microorganisms included reference (from the American Type Culture Collection) and clinical (Laboratory collection) strains of Providencia stuartii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter aerogenes and Enterobacter cloacae (Table 2). They were maintained on agar slant at 4°C and sub-cultured on a fresh appropriate agar plates 24 h prior to any antimicrobial test. Mueller Hinton Agar was used for the activation of bacteria. The Mueller Hinton Broth (MHB) was used for the MIC determinations.

Table 2 Bacterial strains and features

Bacterial susceptibility determinations

The respective MICs of samples on the studied bacteria were determined using rapid INT colorimetric assay [6, 7]. Briefly, the test samples were first dissolved in DMSO/MHB. The solution obtained was then added to MHB, and serially diluted two fold (in a 96-wells microplate). One hundred microlitres (100 μl) of inoculum (1.5 × 106 CFU/ml) prepared in MHB was then added. The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a shaker and incubated at 37°C for 18 h. The final concentration of DMSO was lower than 2.5% and did not affect the microbial growth. Wells containing MHB, 100 μl of inoculum and DMSO at a final concentration of 2.5% served as negative control (this internal control was systematically added). The total volume in each well was 200 μl. Chloramphenicol was used as reference antibiotic. The MICs of samples were detected after 18 h incubation at 37°C, following addition (40 μl) of 0.2 mg/ml INT and incubation at 37°C for 30 minutes. Viable bacteria reduced the yellow dye to pink. MIC was defined as the lowest sample concentration that prevented this change and exhibited complete inhibition of microbial growth [8].

Samples were tested alone and then, in the presence of PAßN at 30 μg/ml final concentration. Two of the best extracts [those from D. glomerata and B. cinnamomea] were also tested in association with antibiotics at MIC/2 and MIC/5. These concentrations were selected following a preliminary assay on one of the tested MDR bacteria, P. aeruginosa PA124 (See Additional file 1, Table A1). All assays were performed in triplicate and repeated thrice. Fractional inhibitory concentration (FIC) was calculated as the ratio of MICAntibiotic in combination/MICAntibiotic alone and the interpretation made as follows: synergistic (< 0.5), indifferent (0.5 to 4), or antagonistic (> 4) [9] (The FIC values available in Additional file 1, Tables A2 and A3).


Phytochemical composition of the spice extracts

The results of the phytochemical studies (Table 3) showed that all the tested extracts contain alkaloids, phenols and tannins. Anthocyanins, anthraquinones, flavonoids, saponins, sterols and triterpenes were selectively present.

Table 3 Extraction yields, aspects and phytochemical composition of the plant extracts.

Antibacterial activity of the spice extracts

The results of the antibacterial activity of the extract alone on a panel of Gram negative bacteria are summarized in Table 4. It appears that the extract from D. glomerata was able to prevent the growth of all the twenty nine tested bacteria with MIC ≤ 1024 μg/ml. All other samples showed selective activity; their inhibitory activity being recorded on 28 of the 29 (96.6%) tested bacteria for B. cinnamomea, 24/29 (82.8%) for A. citratum, 19/29 (62.5%) for P. capense, 18/29 (62.1%) for E. giganteus and F. Xanthoxyloïdes, 15/29 (51.7%) for O. subscorpioïdea, 13/29 (44.8%) for X. aethiopica, 12/29 (41.4%) for M. whitei, 6/29 (20.7%) for S. melongena and 4/29 (13, 79%) for S. zenkeri.

Table 4 Minimal inhibitory concentration (MIC) of the studied spice extracts and CHL on the studied bacterial species.

MIC values below 100 μg/ml (Table 4) were recorded with the extract of B. cinnamomea against Enterobacter aerogenes EA294 (64 μg/ml), E. giganteus on Klebsiella pneumoniae K24 (32 μg/ml) and X. aethiopica on Escherichia coli ATCC10536 and Klebsiella pneumoniae KP63 (64 μg/ml).

Role of efflux pumps in susceptibility of Gram negative bacteria to the tested spice extracts

The various strains and MDR isolates were tested for their susceptibilities to the spice extracts, and reference antibiotic, CHL in the presence of PAßN, a well-known efflux pump inhibitor. The results presented in Table 4 showed that the activity of the extract from D. glomerata significantly increased in the presence of PAßN on 18/26 (69.2%) of the tested bacteria. The MIC values below 100 μg/ml were noted with this extract against E. coli MC4100 and W3110 (< 8 μg/ml), K. pneumoniae KP63 and K24 (< 8 μg/ml and 32 μg/ml respectively) and P. stuartii NAE16 (32 μg/ml). Apart from the extract of D. glomerata, PAßN did not induce an increased activity of other tested extract.

Effects of the association of some spice extracts with antibiotics

To evaluate the possible synergistic effects of the extracts with antibiotics, four of the most active samples (F. xanthoxyloïdes, D. glomerata, B. cinnamomea and O. subscorpioïdea) were selected. A preliminary study using P. aeruginosa PA124, one of the MDR bacteria used in this work, was carried out with ten antibiotics (CLX, AMP, ERY, KAN, CHL, TET, FEP, STR, CIP and NOR) to select the appropriate sub-inhibitory concentrations to be used. The results (see Additional file 1, Table A1) allow the selection of MIC/2 and MIC/5 as the sub-inhibitory concentrations of the extracts from D. glomerata and B. cinnamomea, which were then tested on eight MDR bacteria, E. coli AG100, AG100TET, K. pneumoniae KP55, E. aerogenes EA3, EA27, EA289, CM64 in addition to P. aeruginosa PA124. The results are summarized in Tables 5 and 6. Synergistic effects were observed with the association between D. glomerata (Table 5, Additional file 1, Table A2) and B. cinnamomea ( Table 6, Additional file 1, Table A3) and most of the antibiotics on the studied MDR bacteria. At MIC/2, synergistic effects were noted with the extract of D. glomerata on 25% (2/8) of the tested bacteria for CLX and AMP, 50% (4/8) for KAN, 62.5% (5/8) for CHL, FEP, STR, CIP, 75% (6/8) for ERY and 87.5% (7/8) for NOR and TET. Increase in MIC values of > 8 fold were recorded at MIC/2 with CHL, TET, STR, CIP, NOR (Table 5). At MIC/5, synergistic effects were noted on 50% of the eight tested MDR bacteria in the case of STR and CIP, 62.5% in the case of ERY and 75% in the case of CHL, TET and NOR.

Table 5 Minimal inhibitory concentration (MIC) in μg/ml of antibiotics in the absence and presence of the sub-inhibitory concentrations of D. glomerata extracts against MDR bacteria.
Table 6 Minimal inhibitory concentration (MIC) of antibiotics in the absence and presence of the sub-inhibitory concentrations of B. cinnamomea extract (μg/ml) against some MDR bacteria.

The extract of B. cinnamomea at MIC/2 (Table 6) also induced significant increase of the activity of several antibiotics, the synergistic effects being noted on 25% of the tested bacteria in the case of CLX and AMP, 50% in the case of KAN, 62.5% in the case of FEP and STR, 75% in the case of CHL, TET and CIP, 87.5% in the case of ERY and 100% for NOR. With this extract, synergistic effects were also observed at MIC/5 on 25% of the studied MDR bacteria in the case of CLX and AMP, 37.5% in the case of STR and KAN, 50% in the case of TET, 62.5% in the case of CHL, FEP, NOR and CIP and 75% in the case of ERY.


Phytochemical composition of the spice extracts

Phytochemical screening revealed the presence of several classes of secondary metabolites. Though the detection of such metabolites does not automatically predict the antimicrobial activity of a plant extract, it has clearly been demonstrated that several compounds belonging to the investigated classes of metabolites showed antibacterial activities [4, 1012].

Antibacterial activity of the spice extract

Phytochemicals are routinely classified as antimicrobials on the basis of susceptibility tests that produce MIC in the range of 100 to 1000 μg/ml [13]. Activity is considered to be significant if MIC values are below 100 μg/ml for crude extract and moderate when 100 < MIC < 625 μg/ml [11]. Therefore, the activity recorded with B. cinnamomea and E. giganteus respectively on E. aerogenes EA294 and K. pneumoniae K24, and X. aethiopica on E. coli ATCC10536 and K. pneumoniae KP63 can be considered significant. Alternative criteria have been described by Fabry et al. [14], which consider extracts having MIC values below 8000 μg/ml to have noteworthy antimicrobial activity. Under these less stringent criteria, and considering the fact that the spices tested are used as food ingredients with limited toxicity, the overall activity recorded with several extracts, most notably those of D. glomerata, B. cinnamomea, A. citratum, P. capense, E. giganteus, F. Xanthoxyloïdes and O. subscorpioïdea, could be considered important. Besides, some of the tested samples were more active than CHL used as reference antibiotic on some of the MDR bacteria such as E. cloacae ECCI69 and BM47, E. aerogenes EA27 and EA289, highlighting the importance of the results reported herein. It can be noted that all the investigated phytochemical classes were detected in the extracts of D. glomerata, S. melongena and M. withei. Contrary to D. glomerata extract that exhibited a good spectrum of activity, the inhibition potential of S. melongena and M. withei was lower and seems not in correlation with their chemical composition. This clearly confirms the fact that the presence of secondary metabolites does not automatically predict the antimicrobial activity of a plant extract though it is a good indication of its possible pharmacological potential.

To the best of our knowledge, the antibacterial activity of B. cinnamomea and P. capense is being reported for the first time. Moreover, the present work reports for the first time the activity of the tested spices on MDR bacteria. Nevertheless, the antimicrobial potential of some of the plants or related genus were demonstrated on sensitive strains. Banso and Adeyemo [15] reported the presence of antibacterial tannins in the genus Dichrostachys. Chouna et al. [16] also demonstrated that Beilschmiedia anacardioides was significantly active against Bacillus subtilis, Micrococcus luteus and Streptococcus faecalis. Plants of the genus Echinops such as E. ellenbeckii and E. longisetus were found active on Staphylococcus aureus[17] meanwhile the antibacterial activity of the essential oils and alkaloids from F. xanthoxyloïdes was also documented [18, 19]. The aqueous and ethanol extracts from O. subscorpioïdea were found active on both bacteria and fungi [20]. The results obtained in the present work therefore provide additional information on the studied plants and are in consistence with some of the previous reports.

Role of efflux pumps in susceptibility of Gram negative bacteria to the tested spice extracts

Tripartite efflux systems, mainly those clinically described as AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in P. aeruginosa, are associated with a major human health problem as they play a central role in multidrug resistance of pathogenic Gram negative bacteria [2123]. PAßN has been reported as a potent inhibitor of the RND efflux systems and is especially active on AcrAB-TolC and MexAB-OprM [22, 24, 25]. To determine the role of efflux pumps in this work, the concentration of PAßN used (30 μg/ml) had no intrinsic effect on the bacteria as previously determined [26]. In contrast, with these conditions significant increase of the antibacterial activity of D. glomerata extract was noted, showing that one or more active compounds from this plant could be substrate(s) of efflux pumps acting in resistant strains of E. coli, K. pneumoniae and P. stuartii. These data suggest that possible association of the extract of D. glomerata and efflux pump inhibitor can be envisaged to improve the fight against MDR phenotypes.

Effects of the association of extracts from D. glomerata and B. cinnamomea with antibiotics

The association of natural products such as plant extracts and antibiotics constitutes an alternative in the fight against MDR bacteria. Significant synergistic effects were noted with both D. glomerata and B. cinnamomea extracts when they were associated with several antibiotics. Such effects might be due either to the action of the active compounds or possible inhibition of the efflux pumps by other compounds of the extracts. The lowest synergistic effects were observed with β-lactamines (CLX and AMP), obviously due to the fact their target are localized in the bacterial cell coat. However, the synergistic effects observed indicate that active compounds of the extract could also present different mode(s) of action from those of the studied antibiotics.


The overall results of the present work provide baseline information for the possible use of the studied spice extracts in the treatment of bacterial infections involving MDR phenotypes. In addition to these antibacterial activities, the data reported herein indicated that possible combinations of the extract of D. glomerata with an efflux pump inhibitor, and also the association of extract of this plant as well as that from B. cinnamomea with several antibiotics could be used in the control of bacterial infections involving MDR phenotypes.


  1. 1.

    Kamicker BJ, Sweeney MT, Kaczmarek F, Dib-Hajj F, Shang W, Crimin K, Duignan J, Gootz TD: Bacteria efflux pomp inhibitors. Methods Mol Med. 2008, 142: 187-204. 10.1007/978-1-59745-246-5_15.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Lutz JK, Lee J: Prevalence and Antimicrobial-Resistance of Pseudomonas aeruginosa in Swimming Pools and Hot Tubs. Int J Environ Res Public Health. 2011, 8: 554-564. 10.3390/ijerph8020554.

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Sofowora A: 1993. Medicinal Plants and Traditional Medicine in Africa. 1993, Ibadan, Spectrum Books Limited

    Google Scholar 

  4. 4.

    Cowan MM: Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999, 12: 564-582.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Harborne JB: Phytochemical Methods. 1973, New York, Chapman and Hall

    Google Scholar 

  6. 6.

    Eloff JN: A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998, 64: 711-713. 10.1055/s-2006-957563.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Mativandlela SPN, Lall N, Meyer JJM: Antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root. S Afr J Bot. 2006, 72: 232-237. 10.1016/j.sajb.2005.08.002.

    Article  Google Scholar 

  8. 8.

    Kuete V, Ngameni B, Fotso Simo CC, Kengap Tankeu R, Tchaleu Ngadjui B, Meyer JJM, Lall N, Kuiate JR: Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae). J Ethnopharmacol. 2008, 120: 17-24. 10.1016/j.jep.2008.07.026.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Coutinho HD, Vasconcellos A, Freire-Pessôa HL, Gadelha CA, Gadelha TS, Almeida-Filho GG: Natural products from the termite Nasutitermes corniger lower aminoglycoside minimum inhibitory concentrations. Pharmacogn Mag. 2010, 6: 1-4. 10.4103/0973-1296.59958.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Bruneton J: Pharmacognosie: Phytochimie, Plantes medicinales. 1999, Paris, Tec & Doc, 263-309. 3

    Google Scholar 

  11. 11.

    Kuete V: Potential of Cameroonian plants and derived-products against microbial infections: A review. Planta Med. 2010, 76: 1479-1491. 10.1055/s-0030-1250027.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Kuete V, Efferth T: Cameroonian medicinal plants: Pharmacology and derived natural products. Front Pharmacol. 2010, 1: 1-19.

    Article  Google Scholar 

  13. 13.

    Simões M, Bennett RN, Rosa EA: Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat Prod Rep. 2009, 26: 746-757. 10.1039/b821648g.

    Article  PubMed  Google Scholar 

  14. 14.

    Fabry W, Okemo PO, Ansorg R: Antibacterial activity of East African medicinal plants. J Ethnopharmacol. 1998, 60: 79-84. 10.1016/S0378-8741(97)00128-1.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Banso A, Adeyemo SO: Evaluation of antibacterial properties of tannins isolated from Dichrostachys cinerea. Afr J Biotech. 2007, 6: 1785-1787.

    CAS  Google Scholar 

  16. 16.

    Chouna JR, Nkeng-Efouet PA, Lenta BN, Devkota PK, Neumann B, Stammler HG, Kimbu SF, Sewald N: Antibacterial endiandric acid derivatives from Beilschmiedia anacardioides. Phytochemistry. 2009, 70: 684-688. 10.1016/j.phytochem.2009.02.012.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Hymete A, Iversena TH, Rohloff J, Erkob B: Screening of Echinops ellenbeckii and Echinops longisetus for biological activities and chemical constituents. Phytomedicine. 2005, 12: 675-679. 10.1016/j.phymed.2004.01.013.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Chaaib F, Queiroz EF, Ndjoko K, Diallo D, Hostettmann K: Antifungal and antioxidant compounds from the root bark of Fagara zanthoxyloides. Planta Med. 2003, 64: 616-320.

    Google Scholar 

  19. 19.

    Tatsadjieu LN, Essia Ngang JJ, Ngassoum MB, Etoa FX: Antibacterial and antifungal activity of Xylopia aethiopica, Monodora myristica, Zanthoxylum xanthoxyloides and Zanthoxylum leprieurii from Cameroon. Fitoterapia. 2003, 74: 469-472. 10.1016/S0367-326X(03)00067-4.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Ayandele AA, Adebiyi AO: The phytochemical analysis and antimicrobial screening of extracts of Olax subscorpioïdea. Afr J Biotech. 2007, 6: 868-870.

    Google Scholar 

  21. 21.

    Blot S, Depuydt P, Vandewoude K, De Bacquer D: Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis. 2007, 20: 391-396. 10.1097/QCO.0b013e32818be6f7.

    Article  PubMed  Google Scholar 

  22. 22.

    Pietras A, Bavro VN, Furnham N, Pellegrini-Calace M, Milner-White EJ, Luisi BF: Structure and mechanism of drug efflux machinery in Gram negative bacteria. Curr Drug Target. 2008, 9: 719-728. 10.2174/138945008785747743.

    CAS  Article  Google Scholar 

  23. 23.

    Papadopoulos CJ, Carson CF, Chang BJ, Riley TV: Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1, 8-cineole and α-terpineol. Appl Environ Microbiol. 2008, 74: 1932-1935. 10.1128/AEM.02334-07.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Lomovskaya O, Bostian KA: Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Biochem Pharmacol. 2006, 71: 910-918. 10.1016/j.bcp.2005.12.008.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Pagès J-M, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, Noussair L, Nicolas-Chanoine MH: Efflux Pump, the Masked Side of β-Lactam Resistance in Klebsiella pneumoniae Clinical Isolates. PLoS ONE. 2009, 4: e4817-10.1371/journal.pone.0004817.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Lorenzi V, Muselli A, Bernardini AF, Berti L, Pagès JM, Amaral L, Bolla JM: Geraniol restores antibiotic activities against multidrug-resistant isolate from Gram-negative species. Antimicrob Agents Chemother. 2009, 53: 2209-2211. 10.1128/AAC.00919-08.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Kuete V, Krusche B, Youns M, Voukeng I, Fankam AG, Tankeo S, Lacmata S, Efferth T: Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol. 2011, 134: 803-812. 10.1016/j.jep.2011.01.035.

    Article  PubMed  Google Scholar 

  28. 28.

    Kojima H, Sato N, Hatano A, Ogura H: Sterol glucosides from Prunella vulgaris. Phytochemistry. 1990, 29: 2351-2355. 10.1016/0031-9422(90)83073-A.

    CAS  Article  Google Scholar 

  29. 29.

    Tane P, Bergquist K-E, Tene M, Ngadjui BT, Ayafor JF, Sterner O: Cyclodione, an unsymmetrical dimeric diterpene from Cylicodiscus gabunensis. Tetrahedron. 1995, 51: 11595-11600. 10.1016/0040-4020(95)00720-S.

    CAS  Article  Google Scholar 

  30. 30.

    Kuete V, Eyong KO, Folefoc GN, Beng VP, Hussain H, Krohn K, Nkengfack AE: Antimicrobial activity of the methanolic extract and of the chemical constituents isolated from Newbouldia laevis. Pharmazie. 2007, 62: 552-556.

    CAS  PubMed  Google Scholar 

  31. 31.

    Kuete V, Wansi JD, Mbaveng AT, Kana Sop MM, Tcho Tadjong A, Beng VP, Etoa FX, Wandji J, Marion Meyer JJ, Lall N: Antimicrobial activity of the methanolic extract and compounds from Teclea afzelii (Rutaceae). S Afr J Bot. 2008, 74: 572-576. 10.1016/j.sajb.2008.02.004.

    CAS  Article  Google Scholar 

  32. 32.

    Watcho P, Kamtchouing P, Sokeng S, Moundipa PF, Tantchou J, Essame JL, Koueta N: Reversible antispermatogenic and antifertility activities of Mondia whitei L. in male albino rat. Phytother Res. 2001, 15: 26-29. 10.1002/1099-1573(200102)15:1<26::AID-PTR679>3.0.CO;2-N.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Jones GP, Rao KS, Tucker DJ, Richardson B, Barnes A, Rivett DE: Antimicrobial activity of santalbic acid from the oil of Santalum acuminatum (Quandong). Int J Pharmacogn. 1995, 33: 120-123. 10.3109/13880209509055210.

    CAS  Article  Google Scholar 

  34. 34.

    Cantrell CL, Berhow MA, Phillips BS, Duval SM, Weisleder D, Vaughn SF: Bioactive crude plant seed extracts from the NCAUR oilseed repository. Phytomedicine. 2003, 10: 325-333. 10.1078/094471103322004820.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Das J, Lahan JP, Srivastava RB: Solanum melongena: A potential source of antifungal agent. Indian J Microbiol. 2008, 50: 62-69.

    Article  Google Scholar 

  36. 36.

    Gbewonyo WSK, Candy DJ: Chromatographic isolation of insecticidal amides from Piper guineense roots. J Chromatogr A. 1992, 607: 105-111. 10.1016/0021-9673(92)87059-H.

    CAS  Article  Google Scholar 

  37. 37.

    N'dri K, Bosson KA, Mamyrbekova-Bekro JA, Jean N, Bekro YA: Chemical composition and antioxidant activities of essential. EurJ Sci Res. 2009, 37: 311-318.

    Google Scholar 

  38. 38.

    Kouokam JC, Jahns T, Becker H: Antimicrobial activity of the essential oil and some isolated sulfur-rich compounds from Scorodophloeus zenkeri. Planta Med. 2002, 68: 1082-1087. 10.1055/s-2002-36341.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, Molnar M, Molnar J, Amaral L: Inducement and Reversal of Tetracycline Resistance in Escherichia coli K-12 and Expression of Proton Gradient-Dependent Multidrug Efflux Pump Genes. Antimicrob Agents Chemother. 2005, 49: 3578-3582. 10.1128/AAC.49.8.3578-3582.2005.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Elkins CA, Mullis LB: Substrate competition studies using whole-cell with the major tripartite multidrug efflux pumps of Escherichia coli. Antimicrob Agents Chemother. 2007, 51: 923-929. 10.1128/AAC.01048-06.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Baglioni P, Bini L, Liberatori S, Pallini V, Marri L: Proteome analysis of Escherichia coli W3110 expressing an heterologous sigma factor. Proteomics. 2003, 3: 1060-1065. 10.1002/pmic.200300403.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Ghisalberti D, Masi M, Pagès J-M, Chevalier J: Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun. 2005, 328: 1113-1118. 10.1016/j.bbrc.2005.01.069.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Malléa M, Mahamoud A, Chevalier J, Alibert-Franco S, Brouant P, Barbe J, Pagès JM: Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J. 2003, 376: 801-805. 10.1042/BJ20030963.

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Pradel E, Pagès J-M: The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother. 2002, 46: 2640-2644. 10.1128/AAC.46.8.2640-2643.2002.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Chevalier J, Pagès J-M, Eyraud A, Malléa M: Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae. Biochem Biophys Res Commun. 2000, 274: 496-499. 10.1006/bbrc.2000.3159.

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Tran QT, Mahendra KR, Hajjar A, Ceccarelli M, Davin-Regli A, Winterhalter M, Weingart H, Pagès JM: Implication of Porins in β-Lactam Resistance of Providencia stuartii. J Biol Chem. 2000, 285: 32273-32281.

    Article  Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:

Download references


Authors are thankful to the Cameroon National Herbarium (Yaounde) for plants identification and Mr. Paul K. Lunga and Dr Gerald Ngo Teke for language editing.

Author information



Corresponding author

Correspondence to Victor Kuete.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

PAF carried out the study; VK designed the experiments and wrote the manuscript; VK, IKV, JRK and JMP supervised the work; VK and JMP provided the bacterial strains; All authors read and approved the final manuscript.

Electronic supplementary material

Table S1

Additional file 1: . Activities of antibiotics in combination with the sub-inhibitory concentrations of some plants extracts on Pseudomonas aeruginosa PA124. Table S 2. Fractional Inhibitory Concentrations (FIC) of the association between antibiotics and extract of D. glomerata at MIC/2 and MIC/5 (μg/ml) against MDR bacteria. Table S 3. Fractional Inhibitory Concentrations (FIC) of association between antibiotics and extract of B. cinnamomea at MIC/2 and MIC/5 (μg/ml). (DOC 169 KB)

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Fankam, A.G., Kuete, V., Voukeng, I.K. et al. Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes. BMC Complement Altern Med 11, 104 (2011).

Download citation


  • Antibacterial Activity
  • Minimum Inhibitory Concentration
  • Plant Extract
  • Saponin
  • Anthraquinone